Registro usuarios
FECHAS LÍMITE
20 abril: Inicio de plazo para presentar comunicaciones.
15 de Junio: Fin de la cuota temprana y fin del plazo para envío de comunicaciones.
25 de Julio: Aceptación de comunicaciones orales y pósters.
20 abril: Inicio de plazo para presentar comunicaciones.
15 de Junio: Fin de la cuota temprana y fin del plazo para envío de comunicaciones.
25 de Julio: Aceptación de comunicaciones orales y pósters.
(HALL PENDING)
09:00 am.
“From RNA-editing to smooth muscle contraction: Biomedical implications of RNA modification”
9:30 am.
“The epitranscriptome: a new era for cancer research”
10:00 am.
“Diverse functions of RNA modifications in pluripotency and somatic cell reprogramming”
(HALL PENDING)
9:00 am.
“Small ORFs: from sequence to function”
9:30 am.
“The birth of new proteins from scratch”
10:00 am.
“The microproteome as a source of novel cancer players”
(HALL PENDING)
09:00 am.
Maya Topf, Birkbeck, University of London. United Kingdom.
“Modeling protein structures in (cryo-)EM maps”
09:30 am.
“In vivo architecture of the Exocyst and beyond”
10:00 am.
“Solving protein structures using deep mutagenesis”
(HALL PENDING)
09:00 am.
“Cellular reprogramming of cancer”
09:30 am.
“Novel epigenetic approaches for the treatment of aging and disease”
10:00 am.
“Modulating cellular plasticity in tissue regeneration”
(HALL PENDING))
09:00 am.
09:30 am.
“3DGWAS, genome-wide association studies informed by genome structure”
10:00 am.
“3D genomics and diabetes mellitus”
(HALL PENDING)
09:00 am.
“Biomolecular condensation as a mechanism to regulate gene expression”
09:30 am.
“Understanding Phase Transitions by Deep Mutagenesis”
10:00 am.
“Biomolecular condensates for drug discovery in ALS”
(HALL PENDING)
09:00 am.
“Regulation of gene expression by Stress-Activated Protein Kinases”
09:30 am.
“Spatial-temporal genome architecture: understanding the contribution of non-coding variants to disease development”
10:00 am.
“Dissecting the ChroMetOme: an unexpected metabolism provides novel cancer vulnerabilities”
(HALL PENDING)
09:00 am.
“The nutrients-mTOR axis in cancer and aging”
09:30 am.
“Pathological targets of mTOR in cyst formation and seizures”
10:00 am.
“A substrate-specific mTORC1 pathway mediates selective control of cell metabolism”
(HALL PENDING)
09:00 am.
“DNA targeting by a transposon encoded CRISPR/CAS system”
09: 30 am.
“The Zika virus replicase NS5 in complex with a 5’UTR RNA promoter”
10:00 am.
“Capturing the elusive DNA Mismatch Repair machinery by cryo-EM”